Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports

The management of patients with chronic myeloid leukemia (CML) during pregnancy remains a matter of continuous debate. Tyrosine kinase inhibitors (TKIs) have become the standard of care in managing patients with CML. These drugs have a good safety profile, but animal studies have shown that they are...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Hussain, Jaafar, Hassan, Kajtár, Béla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074472/
https://www.ncbi.nlm.nih.gov/pubmed/26657232
http://dx.doi.org/10.5144/0256-4947.2015.468

Ejemplares similares

Ejemplares similares